当前位置: 首页 > 期刊 > 《医学信息》 > 2016年第12期
编号:12836461
立体定向放疗在乳腺癌脑转移瘤中的系统评价(4)
http://www.100md.com 2016年3月26日 《医学信息》 2016年第12期
     [13]Andrews D W, Scott C B, Sperduto P W, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.[J]. Lancet,2004,363(9422):1665-1672.

    [14]Jo K I, Im Y H, Kong D S, et al. Gamma knife radiosurgery for brain metastases from breast cancer.[J]. J Korean Neurosurg Soc,2013,54(5):399-404.

    [15]Jaboin J J, Ferraro D J, Dewees T A, et al. Survival following gamma knife radiosurgery for brain metastasis from breast cancer.[J]. Radiat Oncol,2013,8(1):131.

    [16]Vern-Gross T Z, Lawrence J A, Case L D, et al. Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgery.[J]. J Neurooncol,2012,110(3):381-388.

    [17]Goyal S, Prasad D, Jr Harrell F, et al. Gamma knife surgery for the treatment of intracranial metastases from breast cancer.[J]. J Neurosurg,2005,103(2):218-223.

    [18]Tam M, Narayana A, Raza S, et al. Role of HER2 status in the treatment for brain metastases arising from breast cancer with stereotactic radiosurgery.[J]. Med Oncol,2014,31(2):832.

    [19]Choi S W, Kwon D H, Kim C J. Clinical outcome in gamma knife radiosurgery for metastatic brain tumors from the primary breast cancer : prognostic factors in local treatment failure and survival.[J]. J Korean Neurosurg Soc,2013,54(4):329-335.

    编辑/蔡睿琳, 百拇医药(简红梅 吴英)
上一页1 2 3 4